0001104659-19-020514.txt : 20190409
0001104659-19-020514.hdr.sgml : 20190409
20190409182704
ACCESSION NUMBER: 0001104659-19-020514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190408
FILED AS OF DATE: 20190409
DATE AS OF CHANGE: 20190409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Merck Sharp & Dohme Corp.
CENTRAL INDEX KEY: 0000942443
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38853
FILM NUMBER: 19740316
BUSINESS ADDRESS:
STREET 1: ONE MERCK DRIVE
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: ONE MERCK DRIVE
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889
FORMER NAME:
FORMER CONFORMED NAME: SCHERING CORP
DATE OF NAME CHANGE: 19950321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38853
FILM NUMBER: 19740317
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER NAME:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER NAME:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NGM BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001426332
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-243-5555
MAIL ADDRESS:
STREET 1: 333 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
a4.xml
4
X0306
4
2019-04-08
0
0001426332
NGM BIOPHARMACEUTICALS INC
NGM
0000310158
Merck & Co., Inc.
2000 GALLOPING HILL ROAD
KENILWORTH
NJ
07033
0
0
1
0
0000942443
Merck Sharp & Dohme Corp.
ONE MERCK DRIVE
WHITEHOUSE STATION
NJ
08889
0
0
1
0
Common Stock
2019-04-08
4
C
0
8833333
A
8833333
I
See Footnote
Common Stock
2019-04-08
4
P
0
4121683
16.00
A
12955016
I
See Footnote
Series E Convertible Preferred Stock
2019-04-08
4
C
0
17666666
0
D
Common Stock
8333333
0
I
See Footnote
Each share of Series E Convertible Preferred Stock automatically converted into one-half (0.5) of a share of common stock immediately prior to the closing of the Issuer's initial public offering, and has no expiration date.
These securities are owned directly by Merck Sharp & Dohme Corp., which is a direct, wholly owned subsidiary of Merck & Co., Inc. ("Merck"). Merck is an indirect beneficial owner of the reported securities.
Merck & Co., Inc. /s/ Faye C. Brown, Senior Assistant Secretary
2019-04-09
Merck Sharp & Dohme Corp., /s/ Faye C. Brown, Assistant Secretary
2019-04-09